BENEFITS OF OUT-OF-THE-BOX CLINICAL DEVELOPMENT ANALYTICS FOR SIEBEL CLINICAL

by Eugene Sefanov

Oracle’s Clinical Development Analytics (CDA) solution can take your clinical trial data to a whole new level; with its dashboards, reporting modules, and analyses, it enables you to slice, dice, and view your data in meaningful ways. But, what exactly do you get with CDA out-of-the-box for Siebel Clinical? How useful is CDA functionality when plugged into Siebel Clinical with no additional configuration?

In this free one-hour presentation, BioPharm’s Mike Grossman, VP of clinical data warehousing and analytics, and Param Singh, VP of clinical trial management solutions, will answer these questions and provide a demonstration of CDA’s features.

Register to view the webinar: https://cc.readytalk.com/r/6gkb9zasp7hj&eom

To learn more about BioPharm, please visit www.biopharm.com.

A Brief Guide to the FDA Drug Approval Process

by Eugene Sefanov

This infographic describes the FDA drug approval process.

FREE WEBINAR: AN EASIER WAY TO PREPARE CLINICAL TRIAL DATA FOR REPORTING AND ANALYSIS

by Eugene Sefanov

Many companies have made great strides in standardizing and conforming subject data collected in clinical trials, in order to have a more efficient and repeatable way of delivering the data to reporting systems for statistical analysis and regulatory submissions.

Typically, preparing data is made up of the following three steps:

1. Specifying the conformed data
2. Programming the conformed specification
3. Validating the written programs work as expected

Please join BioPharm Systems’ Michael Grossman, vice president of clinical data warehousing and analytics, for a complimentary one-hour webinar that will discuss and demonstrate one way to dramatically reduce the effort of specification and validation, as well as remove the programming step in its entirety. The ensuing programs are automatically generated in Oracle Life Sciences Data Hub (LSH) and as standalone SAS. The end result is a significant increase in the productivity of data preparation and conforming for internal use, along with runnable programs that can be sent to regulatory authorities and partners.

Register to view the webinar at https://cc.readytalk.com/r/ntmlnbqr8p6j.

For more information about BioPharm Systems, please visit www.biopharm.com

LEVERAGING ORACLE’S CLINICAL DEVELOPMENT ANALYTICS TO BOOST PRODUCTIVITY AND REDUCE COSTS

by Eugene Sefanov

Oracle’s Clinical Development Analytics (CDA) is a comprehensive analytics solution that provides life sciences sponsors and CROs operational insight into their clinical studies, projects, and programs. Join BioPharm Systems’ Michael Grossman, vice president of clinical data warehousing and analytics, for this one-hour session on CDA to learn how it can be leveraged to answer specific critical business questions by bringing together information from both data management and clinical operations.

You will learn how CDA can:

• Provide insight where and when you need it
• Increase productivity and reduce costs
• Improve clinical operations and data management effectiveness

View a recording of the webinar at https://cc.readytalk.com/r/o00dmtuqp4tl.

For more information about BioPharm Systems, please visit www.biopharm.com.

LEVERAGING ORACLE’S LIFE SCIENCES DATA HUB (LSH) TO ENABLE DYNAMIC CROSS-STUDY ANALYSIS

by Eugene Sefanov

Oracle’s Life Sciences Data Hub (LSH) is a framework that allows sponsors and clinical research organizations to manage clinical trial research data.

One of the most difficult tasks in clinical research is the ability to rapidly bring together and analyze all the relevant data from multiple clinical trials for specific patient subpopulations. This information can be used for many business objectives including monitoring safety risks, planning future trials, and product defense.

Join BioPharm Systems’ Michael Grossman, vice president of clinical data warehousing and analytics, for a free one-hour session on an application within LSH that allows users to dynamically select patient subpopulations and automatically deliver the longitudinal data for those subpopulations for detailed analysis.

You will learn how LSH can:

• Provide dynamic selection of patient subpopulations and automatically generate a longitudinal data mart of the selected subpopulation
• Save and reuse analysis methods and results for future analysis and exploration

View a recording of the webinar at https://cc.readytalk.com/r/691hb42arsm.

For more information about BioPharm Systems, please visit www.biopharm.com.